Index
1 Market Overview of Mood Disorder Treatment
1.1 Mood Disorder Treatment Market Overview
1.1.1 Mood Disorder Treatment Product Scope
1.1.2 Mood Disorder Treatment Market Status and Outlook
1.2 Global Mood Disorder Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mood Disorder Treatment Market Size by Region (2018-2029)
1.4 Global Mood Disorder Treatment Historic Market Size by Region (2018-2023)
1.5 Global Mood Disorder Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mood Disorder Treatment Market Size (2018-2029)
1.6.1 North America Mood Disorder Treatment Market Size (2018-2029)
1.6.2 Europe Mood Disorder Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Mood Disorder Treatment Market Size (2018-2029)
1.6.4 Latin America Mood Disorder Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Mood Disorder Treatment Market Size (2018-2029)
2 Mood Disorder Treatment Market by Type
2.1 Introduction
2.1.1 Medications
2.1.2 Psychotherapy
2.1.3 Brain Stimulation Therapies
2.2 Global Mood Disorder Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mood Disorder Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Mood Disorder Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
3 Mood Disorder Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Specialty Clinic
3.1.3 Others
3.2 Global Mood Disorder Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mood Disorder Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Mood Disorder Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
4 Mood Disorder Treatment Competition Analysis by Players
4.1 Global Mood Disorder Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2022)
4.3 Date of Key Players Enter into Mood Disorder Treatment Market
4.4 Global Top Players Mood Disorder Treatment Headquarters and Area Served
4.5 Key Players Mood Disorder Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Mood Disorder Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 MECTA Corporation
5.1.1 MECTA Corporation Profile
5.1.2 MECTA Corporation Main Business
5.1.3 MECTA Corporation Mood Disorder Treatment Products, Services and Solutions
5.1.4 MECTA Corporation Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 MECTA Corporation Recent Developments
5.2 Ectron Limited
5.2.1 Ectron Limited Profile
5.2.2 Ectron Limited Main Business
5.2.3 Ectron Limited Mood Disorder Treatment Products, Services and Solutions
5.2.4 Ectron Limited Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Ectron Limited Recent Developments
5.3 Somatics, LLC.
5.3.1 Somatics, LLC. Profile
5.3.2 Somatics, LLC. Main Business
5.3.3 Somatics, LLC. Mood Disorder Treatment Products, Services and Solutions
5.3.4 Somatics, LLC. Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Alkermes Recent Developments
5.4 Alkermes
5.4.1 Alkermes Profile
5.4.2 Alkermes Main Business
5.4.3 Alkermes Mood Disorder Treatment Products, Services and Solutions
5.4.4 Alkermes Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Alkermes Recent Developments
5.5 Eli Lilly and Company
5.5.1 Eli Lilly and Company Profile
5.5.2 Eli Lilly and Company Main Business
5.5.3 Eli Lilly and Company Mood Disorder Treatment Products, Services and Solutions
5.5.4 Eli Lilly and Company Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly and Company Recent Developments
5.6 Janssen Global Services, LLC (Johnson & Johnson)
5.6.1 Janssen Global Services, LLC (Johnson & Johnson) Profile
5.6.2 Janssen Global Services, LLC (Johnson & Johnson) Main Business
5.6.3 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Products, Services and Solutions
5.6.4 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Janssen Global Services, LLC (Johnson & Johnson) Recent Developments
5.7 Allergan (AbbVie Inc.)
5.7.1 Allergan (AbbVie Inc.) Profile
5.7.2 Allergan (AbbVie Inc.) Main Business
5.7.3 Allergan (AbbVie Inc.) Mood Disorder Treatment Products, Services and Solutions
5.7.4 Allergan (AbbVie Inc.) Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Allergan (AbbVie Inc.) Recent Developments
5.8 Pfizer Inc.
5.8.1 Pfizer Inc. Profile
5.8.2 Pfizer Inc. Main Business
5.8.3 Pfizer Inc. Mood Disorder Treatment Products, Services and Solutions
5.8.4 Pfizer Inc. Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Inc. Recent Developments
5.9 Mylan N.V.
5.9.1 Mylan N.V. Profile
5.9.2 Mylan N.V. Main Business
5.9.3 Mylan N.V. Mood Disorder Treatment Products, Services and Solutions
5.9.4 Mylan N.V. Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Mylan N.V. Recent Developments
5.10 Novartis AG
5.10.1 Novartis AG Profile
5.10.2 Novartis AG Main Business
5.10.3 Novartis AG Mood Disorder Treatment Products, Services and Solutions
5.10.4 Novartis AG Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Novartis AG Recent Developments
6 North America
6.1 North America Mood Disorder Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Mood Disorder Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mood Disorder Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mood Disorder Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mood Disorder Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mood Disorder Treatment Market Dynamics
11.1 Mood Disorder Treatment Industry Trends
11.2 Mood Disorder Treatment Market Drivers
11.3 Mood Disorder Treatment Market Challenges
11.4 Mood Disorder Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List